News

Currently open positions at the Czech Centre for Phenogenomics

24. 06. 2024 Information Jobs

PROJECT MANAGER – PROJECT ADMINISTRATION TEAM LEADER PROJECT MANAGER POSTDOC/JUNIOR RESEARCHER FOCUSED ON ANGELMAN SYNDROME RESEARCH AND THERAPY DEVELOPMENT POSTDOC/JUNIOR RESEARCHER FOCUSED PRADER-WILLI SYNDROME RESEARCH AND THERAPY DEVELOPMENT POSTDOC/JUNIOR RESEARCHER FOCUSED NOVEL SPATA5 SYNDROME RESEARCH AND THERAPY DEVELOPMENT HEAD/DEPUTY HEAD OF TRANSGENIC AND ARCHIVING MODULE POSTDOC/JUNIOR RESEARCHER FOCUSED ON RARE DISEASE MODEL DEVELOPMENT JUNIOR RESEARCHER…

Keynote and invited speakers of the 6th CCP Phenogenomics Conference announced

We are delighted to announce the keynote and invited speakers of the 6th CCP Phenogenomics Conference 2024: Keynote speakers: Invited speakers:

IMPC Fall Meeting

04. 06. 2024 Event

15 – 16 September 2024, Prague, Czech Republic / The Fall KOMP-IMPC (International Mouse Phenotyping Consortium) meeting will be hosted by the Czech Centre for Phenogenomics. Draft programme: Venue: Institute of Molecular Genetics of the Czech Academy of Sciences Registration is open. Registration for both on-site and on-line participation in the IMPC meeting is obligatory.…

Science Fair 2024 has started today and CCP is there

30. 05. 2024 Information

Organised annually by the Czech Academy of Sciences since 2015, the Science Fair is one of the largest popular educational events in the Czech Republic. Over an exhibition area of over 8,000m², visitors can view over 100 exhibitions from more than 90 exhibitors. Among the exhibitors you find scientific institutions and educational, innovative and technological…

Meeting of patient organisations with journalists / Setkání pacientských organizací s novináři

24. 05. 2024 Event

18 June 2024, 9:00 – 12:30, Prague, Czech Republic / The second Meeting of Patient Organisations with Journalists organised by the Academy of Patient Organisations (APO) will take place on 18 June 2024 in the morning (9.00-12.30) at Worklounge Příkopy, entrance Panská 845/2, Prague. 4 patient organisations will present their projects at the meeting. In…

Gene and precision therapy – a new hope for the treatment of human diseases / Genová a přesná terapie – nová naděje pro léčbu lidských chorob

22. 05. 2024 Event Lecture

1 June 2024, Prague (PVA Letňany), Czech Republic / Is gene therapy a revolution in the treatment of incurable diseases? How can DNA be altered? Is it safe? Could gene therapy be a bridge to genetic enhancement of humans? Answers to these key questions await you, and we’ll take a peek into the future. Lecture…

LAST CHANCE to apply for free cancer services via canSERV project!

14. 05. 2024 Call News

The Czech Centre for Phenogenomics is among the esteemed service providers for the pan-European cancer project – canSERV. Along with other INFRAFRONTIER partners, our cutting-edge cancer services are among the following offered via the project: More information about these services can be found HERE. Apply now to get FREE-OF-CHARGE access to any of these services following this link:…

Czech Centre for Phenogenomics at the Czech Science Fair / České centrum pro fenogenomiku na Veletrhu vědu

13. 05. 2024 Education Event

30 May –⁠ 1 June 2024, Prague (PVA Letňany), booth/stánek 48 / We are from the Czech Centre for Phenogenomics at the Institute of Molecular Genetics of the CAS, located in the outskirts of Prague in Vestec in the BIOCEV complex. And what exactly does phenogenomics mean and what do we do? Phenogenomics is a field…

19th Transgenic Technology Meeting (TT2025)

07. 05. 2024 Event

24 – 27 April 2025, Zurich, Switzerland / For more information visit: https://tt2025.org/

canSERV Call for Service Provision on “Reaching an Understanding of Cancer”

23. 04. 2024 Call News

The canSERV Consortium is pleased to announce the launch of its 2nd Challenge-Driven Call on “Reaching an Understanding of Cancer”. Cancer Researchers world-wide are invited to apply for free access to cutting-edge transnational services with an indicative overall budget for this call of EUR 750.000. The primary objective of this call is to accelerate research…

1 2 3 25